{
  "trial_id": "NCT03395756",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "midluteal phase of their cycle, and will be enrolled if a serum progesterone level is >3ng/ml.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Healthy women of reproductive age (18-39 years old) with BMI 18-30 kg/m2",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Regular menses for the last 3 months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Cycle duration 24 to 35 days",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "English- or Spanish-speaking",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any contraindications to progesterone contraception per teh CDC Medical Eligibility Criteria (Category 3 or 4)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "On medications that can alter, or be altered by, progesterone contraceptive steroid hormone (e.g., aminoglutethimide or other anti-steroid medication)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has myasthenia gravis and takes pyridostigmine, but this does not appear to be a contraindication for progesterone contraception. She also has hypertension in her father, but this is not a direct exclusion criterion.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT03395756",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}